Scott Randal W. 4
4 · BridgeBio Pharma, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Scott Randal W.
Director
Transactions
- Sale
Common Stock
2024-03-01$34.00/sh−2,500$85,000→ 6,500 total(indirect: By LLC)
Holdings
- 5,000
Common Stock
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023.